SOUTH KOREA · OPENDART
Genesystem Co., Ltd
진시스템 · 363250 · KOSDAQ · Healthcare · Diagnostics & Research
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
No exchange purchase by an insider is on record yet.
Other changes in holdings · 5
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-04-01 | 에이치투자조합 | 10% shareholder | Paid-in capital increase by third-party allotment(+) | 715,138 | DART ↗ |
| 2026-03-20 | PARK YOUNG WON | Managing director | Exercise of appraisal rights(+) | 15,006 | DART ↗ |
| 2026-02-27 | 에이치투자조합 | 10% shareholder | Paid-in capital increase by third-party allotment(+) | 715,138 | DART ↗ |
| 2024-12-03 | HONG SA CHEOL | Vice president | 주식매수선택권(+) | 4,502 | DART ↗ |
| 2024-12-03 | PARK YOUNG WON | Managing director | 주식매수선택권(+) | 16,500 | DART ↗ |